Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial

• Erwin Birnie,
• Cornelis Verhoef,
• Reno Debets,
• Taco M A L Klem,
• Adriaan Moelker,
• Elles M F van de Voort,
• Gerson M Struik,
• Linetta B Koppert,
• Glenn Yo,
• Maura J P V Macco,
• Renata H J A Sinke,
• Martine Franckena

Affiliations

Erwin Birnie

Department of Statistics and Education, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands

Cornelis Verhoef

Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands

Reno Debets

Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands

Taco M A L Klem

Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands

Adriaan Moelker

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

Elles M F van de Voort

Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands

Gerson M Struik

Department of Surgery, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands

Linetta B Koppert

Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, The Netherlands

Glenn Yo

Department of Radiology, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands

Maura J P V Macco

Department of Radiology, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands

Renata H J A Sinke

Department of Pathology, Pathan B.V, Rotterdam, The Netherlands

Martine Franckena

Department of Radiotherapy, Erasmus Medical Center, Rotterdam, The Netherlands